ID   CHLA-20
AC   CVCL_6602
SY   CHLA20
DR   Cell_Model_Passport; SIDM01539
DR   Cosmic; 1890108
DR   Wikidata; Q54812179
RX   PubMed=9850071;
RX   PubMed=23202128;
RX   PubMed=24792489;
WW   Provider; CCR; -; https://www.cccells.org/dl/NB_Data_Sheets/CHLA-20_Cell_Line_Data_Sheet_COGcell_org.pdf
CC   Doubling time: 28 hours (COG).
ST   Source(s): COG
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 13
ST   D18S51: 15,19
ST   D19S433: 14,15
ST   D21S11: 30,31.2
ST   D2S1338: 17
ST   D3S1358: 16
ST   D5S818: 12,15
ST   D7S820: 9,11
ST   D8S1179: 13
ST   FGA: 23,24
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6594 ! CHLA-15
SX   Female
AG   2Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
RX   PubMed=9850071;
RA   Keshelava N., Seeger R.C., Groshen S., Reynolds C.P.;
RT   "Drug resistance patterns of human neuroblastoma cell lines derived
RT   from patients at different phases of therapy.";
RL   Cancer Res. 58:5396-5405(1998).
//
RX   PubMed=23202128; DOI=10.1038/ng.2493; PMCID=PMC3557959;
RA   Sausen M., Leary R.J., Jones S., Wu J., Reynolds C.P., Liu X.-Y.,
RA   Blackford A.L., Parmigiani G., Diaz L.A. Jr., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E., Hogarty M.D.;
RT   "Integrated genomic analyses identify ARID1A and ARID1B alterations in
RT   the childhood cancer neuroblastoma.";
RL   Nat. Genet. 45:12-17(2013).
//
RX   PubMed=24792489; DOI=10.1007/s11060-014-1456-8;
RA   Farooqi A.S., Dagg R.A., Choi L.M.R., Shay J.W., Reynolds C.P.,
RA   Lau L.M.S.;
RT   "Alternative lengthening of telomeres in neuroblastoma cell lines is
RT   associated with a lack of MYCN genomic amplification and with p53
RT   pathway aberrations.";
RL   J. Neurooncol. 119:17-26(2014).
//